In Belgium, the responsibilities for research are divided between Belgium’s Communities and the federal state. The budget for scientific research in the drugs field is provided under the Federal Drug Policy Note and is managed by the Belgian Federal Science Policy Office (BELSPO) through a research programme that supports federal policy. Most studies funded through this programme are carried out by networks of researchers. The national focal point for the EMCDDA may also be a partner in these studies and is often involved in guidance committees. In addition, the national focal point collects information on ongoing and completed studies in Belgium and disseminates information on drug-related research findings to different audiences through a variety of channels.
Recent drug-related research in Belgium includes population-based and clinical studies of epidemiology, treatment interventions and drug market analysis. Drug-related research is frequently published in national and international scientific journals.